Bristol-Myers Squibb discontinues Coumadin brand of warfarinGeneric alternatives still marketed, but some strengths of one generic product currently in short supply Ontario introduces COVID-19 advance payment plan despite objections from doctorsThe Ontario Medical Association put forward several additional proposals to maintain outpatient healthcare infrastructure during the pandemic; they were rejected Pharmacists cautioned about suppliers capitalizing on PPE shortages The BC Pharmacy Association warned that some pharmacies have been asked to put down large advance payments for PPE to companies that may not deliver Amputations, organ failure, blood clotting: the range of complications in COVID-19 cases Feds to announce new measures to mobilize scientists in COVID-19 fight NS to cover extra dispensing fees arising from 30-day prescription limits As NS steps up, the OPA and CARP have been lobbying Ontario to do the same Oncology drugs are largest category in pipeline, review board reports Infoway to support EMR vendors in enhancing virtual care in pandemic Canadian interim guidelines for managing patients with moderate to severe COVID-19 Provide advice on timely, effective and safe supportive management of adults and children with suspected or confirmed COVID-19 Science summary: A look at novel coronavirus research in Canada and around the globe First Previous 827 828 829 830 831 Next Last
